These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 11361511)
21. [New classes of drug for treating HIV infections]. Med Monatsschr Pharm; 2000 Mar; 23(3):100-2. PubMed ID: 10798930 [No Abstract] [Full Text] [Related]
22. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs. Cohen J Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049 [No Abstract] [Full Text] [Related]
23. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Cohen J Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654 [No Abstract] [Full Text] [Related]
24. A rare moment in time. Huff B GMHC Treat Issues; 2007; 21(1):12. PubMed ID: 17722333 [No Abstract] [Full Text] [Related]
25. [Approval of a new nucleoside. Component of complete once daily regimen]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373067 [No Abstract] [Full Text] [Related]
26. Integration of salvage research into existing networks and structures. Evans D Res Initiat Treat Action; 2004; 10(1):22-3. PubMed ID: 15595168 [No Abstract] [Full Text] [Related]
27. AIDS research. Drug trials without the drugs? Cohen J Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159 [No Abstract] [Full Text] [Related]
28. WHO approves combination pills for HIV/AIDS. Fleck F BMJ; 2003 Nov; 327(7423):1067. PubMed ID: 14604912 [No Abstract] [Full Text] [Related]
29. [Therapeutic aspects of HIV/AIDS infected patients and evaluation of therapeutic protocols]. Reszketö Z; Szlávik J; Balogh J; Vincze Z Acta Pharm Hung; 2001 Dec; 71(4):428-32. PubMed ID: 12113183 [TBL] [Abstract][Full Text] [Related]
30. Botswana gets boost in AIDS funding. AIDS Patient Care STDS; 2010 Oct; 24(10):685. PubMed ID: 20945534 [No Abstract] [Full Text] [Related]
31. Options for first line therapy. Proj Inf Perspect; 1999 Apr; (27):7-8. PubMed ID: 11366741 [TBL] [Abstract][Full Text] [Related]
32. New drugs in development. Proj Inf Perspect; 2000 Mar; (29):8-9. PubMed ID: 12769052 [TBL] [Abstract][Full Text] [Related]
33. New classes of HIV drugs on the horizon. A review of the presentation at the satellite symposium "New hope: advancing care in HIV infection" at the 15th annual Association of Nurses in AIDS Care conference, November 2002. O'Brien WA AIDS Read; 2003 Mar; 13(3 Suppl):S4-8. PubMed ID: 12765159 [TBL] [Abstract][Full Text] [Related]
34. Commentary: the reality of treating HIV and AIDS in poor countries. Sykes R BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203 [No Abstract] [Full Text] [Related]
35. New horizons in the treatment of HIV. HIV Inside; 2003; 5(3):1, 3-8, 11-2. PubMed ID: 14974422 [No Abstract] [Full Text] [Related]
36. New targets bring new challenges. Huff B GMHC Treat Issues; 2002 Mar; 16(3):4-6. PubMed ID: 12004798 [No Abstract] [Full Text] [Related]
37. Anti-HIV agents. Treatments for drug-resistant HIV coming. TreatmentUpdate; 2007; 19(5):1-2. PubMed ID: 17955612 [No Abstract] [Full Text] [Related]
38. Opportunistic pricing: a new scourge, a new call for action. Proj Inf Perspect; 1998 Dec; (26):1-5. PubMed ID: 11366486 [TBL] [Abstract][Full Text] [Related]
39. Is pharmaceutical R&D just a game of chance or can strategy make a difference? Schmid EF; Smith DA Drug Discov Today; 2004 Jan; 9(1):18-26. PubMed ID: 14761802 [TBL] [Abstract][Full Text] [Related]
40. Regulatory issues and challenges in salvage therapy. Delaney M Res Initiat Treat Action; 2004; 10(1):29-30. PubMed ID: 15595171 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]